TY - JOUR
T1 - 19 Channel Z-Score and LORETA Neurofeedback
T2 - Does the Evidence Support the Hype?
AU - Coben, Robert
AU - Hammond, D Corydon
AU - Arns, Martijn
N1 - Funding Information:
MA reports options from Brain Resource (Sydney, Australia); is director and owner of Research Institute Brainclinics, a minority shareholder in neuroCare Group (Munich, Germany), and a co-inventor on 4 patent applications (A61B5/0402; US2007/0299323, A1; WO2010/139361 A1; WO2017/099603 A1) related to EEG, neuromodulation and psychophysiology, but does not own these nor receives any proceeds related to these patents; Research Institute Brainclinics received research funding from Brain Resource (Sydney, Australia) and neuroCare Group (Munich, Germany), and equipment support from Deymed, neuroConn and Magventure, however data analyses and writing of this manuscript were unconstrained. RC is the co-director if Integrated Neuroscience Services and one of the creators of four channel multivariate coherence neurofeedback. Analyses and writing of this manuscript were unconstrained and affected by these. CH has no disclosures of interest.
Publisher Copyright:
© 2018, The Author(s).
PY - 2019/3
Y1 - 2019/3
N2 - Neurofeedback is a well-investigated treatment for ADHD and epilepsy, especially when restricted to standard protocols such as theta/beta, slow cortical potentials and sensori-motor rhythm neurofeedback. Advances in any field are welcome and other techniques are being pursued. Manufacturers and clinicians are marketing 'superior' neurofeedback approaches including 19 channel Z-score neurofeedback (ZNFB) and 3-D LORETA neurofeedback (with or without Z-scores; LNFB). We conducted a review of the empirical literature to determine if such claims were warranted. This review included the above search terms in Pubmed, Google scholar and any references that met our criteria from the ZNFB publication list and was restricted to group based studies examining improvement in a clinical population that underwent peer review (book chapters, magazine articles or conference presentations are not included since these are not peer reviewed). Fifteen relevant studies emerged with only six meeting our criterion. Based on review of these studies it was concluded that empirical validation of these approaches is sorely lacking. There is no empirical data that supports the notion that 19-channel z-score neurofeedback is effective or superior. The quality of studies for LNFB was better compared to ZNFB and some suggestion for efficacy was demonstrated for ADHD and Tinnitus distress. However, these findings need to be replicated, extended to other populations and have yet to show any "superiority." Our conclusions continue to emphasize the pervasive lack of evidence supporting these approaches to neurofeedback and the implications of this are discussed.
AB - Neurofeedback is a well-investigated treatment for ADHD and epilepsy, especially when restricted to standard protocols such as theta/beta, slow cortical potentials and sensori-motor rhythm neurofeedback. Advances in any field are welcome and other techniques are being pursued. Manufacturers and clinicians are marketing 'superior' neurofeedback approaches including 19 channel Z-score neurofeedback (ZNFB) and 3-D LORETA neurofeedback (with or without Z-scores; LNFB). We conducted a review of the empirical literature to determine if such claims were warranted. This review included the above search terms in Pubmed, Google scholar and any references that met our criteria from the ZNFB publication list and was restricted to group based studies examining improvement in a clinical population that underwent peer review (book chapters, magazine articles or conference presentations are not included since these are not peer reviewed). Fifteen relevant studies emerged with only six meeting our criterion. Based on review of these studies it was concluded that empirical validation of these approaches is sorely lacking. There is no empirical data that supports the notion that 19-channel z-score neurofeedback is effective or superior. The quality of studies for LNFB was better compared to ZNFB and some suggestion for efficacy was demonstrated for ADHD and Tinnitus distress. However, these findings need to be replicated, extended to other populations and have yet to show any "superiority." Our conclusions continue to emphasize the pervasive lack of evidence supporting these approaches to neurofeedback and the implications of this are discussed.
KW - Attention Deficit Disorder with Hyperactivity/therapy
KW - Electroencephalography
KW - Equipment and Supplies/standards
KW - Evidence-Based Medicine
KW - Humans
KW - Neurofeedback/physiology
KW - ADHD
KW - METAANALYSIS
KW - HYPERACTIVITY
KW - EEG
KW - SLOW CORTICAL POTENTIALS
KW - Multichannel neurofeedback
KW - Review
KW - BIOFEEDBACK
KW - LORETA neurofeedback
KW - CHILDREN
KW - TRIAL
KW - ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
KW - ADOLESCENTS
KW - Z-Score neurofeedback
U2 - 10.1007/s10484-018-9420-6
DO - 10.1007/s10484-018-9420-6
M3 - (Systematic) Review article
C2 - 30255461
SN - 1090-0586
VL - 44
SP - 1
EP - 8
JO - Applied Psychophysiology and Biofeedback
JF - Applied Psychophysiology and Biofeedback
IS - 1
ER -